OmeCare COVID-19 RT-PCR is a clinical use, prescription only, molecular diagnostic test that can diagnose a patient with an active COVID-19 infection by qualitatively detecting nucleic acid (RNA) from SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs. Utilizing reverse transcriptase-polymerase chain reaction, or RT-PCR, the OmeCare COVID-19 RT-PCR test is highly accurate, with an over 96% specificity and sensitivity to the novel COVID-19 coronavirus.

OmeCare’s CLIA certified laboratory performs the final testing of the sample utilizing the Fluidigm Advanta Dx SARS-CoV-2 RT-PCR Assay Omecare has filed EUA202339.